trio.jpg
Translational Research in Oncology (TRIO) Appoints Industry and Clinical Experts to Board of Directors
February 03, 2020 10:00 ET | Translational Research in Oncology
EDMONTON, Alberta, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced the appointment of two new members...
trio.jpg
Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111
November 14, 2019 08:00 ET | Translational Research in Oncology
EDMONTON, Alberta, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced enrolment of the first patient in a...
trio.jpg
Translational Research in Oncology (TRIO) Partners With Molecular Templates for First-In-Human Phase I Study for MT-5111
April 25, 2019 10:06 ET | Translational Research in Oncology
EDMONTON, Alberta, April 25, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced it has partnered with Molecular...
trio.jpg
Исследовательский центр  TRIO включает первого пациента в клиническое исследование III фазы по программе борьбы с раком молочной железы NATALEE
January 16, 2019 01:21 ET | Translational Research in Oncology
Эдмонтон, Альберта, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) в сотрудничестве с Novartis и под руководством доктора медицинских наук, председателя правления и...
trio.jpg
TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial
January 14, 2019 10:15 ET | Translational Research in Oncology
EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO...
trio.jpg
TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
July 09, 2018 16:16 ET | Translational Research in Oncology
EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib...
trio.jpg
TRIO Announces Participation in the Avoca Diligent™ Prequalification Platform
January 24, 2018 07:00 ET | Translational Research in Oncology
EDMONTON, Alberta, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO) is pleased to announce its participation in the Avoca Diligent™ Prequalification Platform. The purpose...